Galvez, M., Castaneda, C., Sanchez, J., Castillo, M., Rebaza, L., Calderon, G., . . . Gomez, H. (2018). Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.
Citación estilo ChicagoGalvez, M., et al. Clinicopathological Predictors of Long-term Benefit in Breast Cancer Treated With Neoadjuvant Chemotherapy. 2018.
Cita MLAGalvez, M., et al. Clinicopathological Predictors of Long-term Benefit in Breast Cancer Treated With Neoadjuvant Chemotherapy. 2018.
Precaución: Estas citas no son 100% exactas.